• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session

    9/13/22 12:32:58 PM ET
    $AAPL
    $ADTX
    $AEHR
    $AKRO
    Computer Manufacturing
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAPL alert in real time by email

    Gainers

    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
    • Akero Therapeutics, Inc. (NASDAQ:AKRO) shares climbed 111% to $25.88 after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) rose 47.4% to $2.83 after a late Monday Form 4 filing showed multiple insider purchases of the stock.
    • 89bio, Inc. (NASDAQ:ETNB) shares gained 32.4% to $6.62. Analysts reportedly said Akero's NASH data could be a positive for the company's Pegoza program in NASH.
    • VNET Group, Inc. (NASDAQ:VNET) surged 30.7% to $6.13 after the company announced the receipt of a preliminary non-binding proposal to acquire all of its shares and formation of a special committee to review the proposal.
    • Hycroft Mining Holding Corporation (NASDAQ:HYMC) gained 28% to $1.0199. The company earlier reported initial drill results from its 2022-2023 exploration program.
    • Aditxt, Inc. (NASDAQ:ADTX) gained 26% to $0.2188.
    • Aprea Therapeutics, Inc. (NASDAQ:APRE) jumped 26% to $1.00.
    • Planet Labs PBC (NYSE:PL) rose 15.1% to $6.24 after the company reported better-than-expected Q2 results and raised guidance.
    • Tyme Technologies, Inc. (NASDAQ:TYME) rose 14.7% to $0.2950 after gaining around 4% on Monday.
    • Fresh Track Therapeutics, Inc. (NASDAQ:FRTX) surged 14.7% to $2.42. Fresh Tracks Therapeutics initiated multiple ascending dose portion of Phase 1 study of DYRK1A inhibitor FRTX-02.
    • Motorsport Games Inc. (NASDAQ:MSGM) gained 13.7% to $0.8603. Motorsport Games, last month, reported worse-than-expected Q2 EPS results.
    • Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) rose 13.3% to $17.16. S&P Dow Jones Indices said Catalyst Pharmaceuticals will replace Mantech International Corp. in S&P Smallcap 600 on September 15.
    • Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) shares rose 13% to $0.8250 after the FDA granted Syros Pharmaceuticals Orphan Drug Designation for the treatment of pancreatic cancer.
    • Tyme Technologies, Inc. (NASDAQ:TYME) jumped 11.9% to $0.2880.
    • Aehr Test Systems (NASDAQ:AEHR) gained 11.4% to $15.70 after the company received a wafer level burn-in system order.
    • Celularity Inc. (NASDAQ:CELU) rose 11.3% to $2.6050.
    • iBio, Inc. (NYSE:IBIO) rose 10.6% to $0.2996 after declining over 4% on Monday.
    • Blue Star Foods Corp. (NASDAQ:BSFC) gained 10.3% to $1.17 as the company signed a one-year extension to its multi-year supply contract with Sysco Corp.
    • Yoshiharu Global Co. (NASDAQ:YOSH) rose 8.8% to $3.3214.
    • LSB Industries, Inc. (NYSE:LXU) gained 6.9% to $17.13. Piper Sandler initiated coverage on LSB Industries with an Overweight rating and announced a price target of $26.
    • Core & Main, Inc. (NYSE:CNM) rose 3.7% to $25.40 following upbeat Q2 results.


    Losers

    • Cardiff Oncology, Inc. (NASDAQ:CRDF) fell 32% to $2.1799. Following a strategic review, Cardiff Oncology decided it will not independently fund any future clinical activities in metastatic castrate-resistant prostate cancer (mCRPC), citing clinical data and therapeutic landscape.
    • Rent the Runway, Inc. (NASDAQ:RENT) shares fell 31.5% to $3.3750 after the company reported issued Q3 guidance below estimates and announced a workforce reduction of 24% of corporate employees. Credit Suisse downgraded the stock from Outperform to Neutral and lowered the price target from $7 to $4.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) fell 29% to $1.1850 after the company priced 13.33 million share offering plus accompanying warrants at combined price of $1.50 per share plus warrant.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) fell 21.3% to $14.79. InMed Pharmaceuticals recently announced a $6 million private placement priced at $8.68 per share.
    • Tuesday Morning Corporation (NASDAQ:TUEM) dropped 21% to $0.1529. The company recently announced it has entered into an agreement to secure $32 million in convertible debt financing.
    • Benitec Biopharma Inc. (NASDAQ:BNTC) declined 19.3% to $0.5125 as the company reported pricing of $18 million underwritten public offering.
    • PolyPid Ltd. (NASDAQ:PYPD) fell 18.1% to $1.3992 after jumping 58% on Monday. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week.
    • Nocera, Inc. (NASDAQ:NCRA) declined 17% to $2.10.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) dropped 16% to $0.8990 after the company discontinued ongoing Phase 1 trials of RTX-240 and RTX-224 in advanced solid tumors.
    • Braze, Inc. (NASDAQ:BRZE) fell 15% to $37.00 after the company reported Q2 earnings results and issued Q3 2023 adjusted EPS guidance below estimates.
    • Relay Therapeutics, Inc. (NASDAQ:RLAY) shares fell 14.9% to $24.51. Relay Therapeutics priced 11.32 million share public offering of common stock at $26.50 per share.
    • Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) dropped 14.5% to $26.64.
    • WalkMe Ltd. (NASDAQ:WKME) declined 14.4% to $9.47. WalkMe announced the departure of Chief Financial Officer Andrew Casey.
    • AMTD Digital Inc. (NYSE:HKD) declined 13.8% to $50.20.
    • BridgeBio Pharma, Inc. (NASDAQ:BBIO) fell 14% to $10.64.
    • Pacific Biosciences of California, Inc. (NASDAQ:PACB) dipped 13.5% to $6.01.
    • Peloton Interactive, Inc. (NASDAQ:PTON) fell 13.5% to $9.55 after the company announced Executive Chair John Foley will step down, effective Sept. 12. Karen Boone has been elected Chairperson of the Board.
    • Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) slipped 13.4% to $13.93.
    • Carvana Co. (NYSE:CVNA) fell 12.4% to $37.02.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) dropped 12% to $2.7690.
    • Wayfair Inc. (NYSE:W) fell 11.7% to $49.40.
    • Unity Software Inc. (NYSE:U) dropped 11.4% to $37.48 after Applovin announced it does not intend to submit another proposal to combine with the company and has withdrawn its Aug. 9 proposal.
    • Asana, Inc. (NYSE:ASAN) fell 10.3% to $25.75.
    • Upstart Holdings, Inc. (NASDAQ:UPST) dipped 9% to $25.47.
    • AppLovin Corporation (NASDAQ:APP) fell 6.1% to $26.76. Applovin announced it does not intend to submit another proposal to combine with Unity Software and has withdrawn its Aug. 9 proposal.
    • Amazon.com, Inc. (NASDAQ:AMZN) dipped 5.8% to $128.55 after August CPI data showed greater-than-expected US inflation.
    • Microsoft Corporation (NASDAQ:MSFT) fell 4.3% to $255.23 after August CPI data showed greater-than-expected US inflation.
    • Apple Inc. (NASDAQ:AAPL) fell 4.1% to $156.76 amid overall market weakness after August CPI readings showed inflation came in greater than expected.
    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $ADTX
    $AEHR
    $AKRO

    CompanyDatePrice TargetRatingAnalyst
    Wayfair Inc.
    $W
    2/20/2026$114.00 → $105.00Overweight
    Analyst
    Upstart Holdings Inc.
    $UPST
    2/17/2026$30.00Sell → Neutral
    Compass Point
    Upstart Holdings Inc.
    $UPST
    2/13/2026$20.00Mkt Perform → Mkt Underperform
    Citizens
    Upstart Holdings Inc.
    $UPST
    2/13/2026$35.00Sell → Neutral
    Goldman
    Apple Inc.
    $AAPL
    2/10/2026$325.00 → $340.00Outperform
    Bernstein
    Peloton Interactive Inc.
    $PTON
    2/10/2026Buy → Hold
    Argus
    Unity Software Inc.
    $U
    2/10/2026$38.00Perform → Outperform
    Oppenheimer
    Microsoft Corporation
    $MSFT
    2/9/2026Buy → Hold
    Melius
    More analyst ratings

    $AAPL
    $ADTX
    $AEHR
    $AKRO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stanton John W bought $1,986,750 worth of shares (5,000 units at $397.35), increasing direct ownership by 6% to 83,905 units (SEC Form 4)

    4 - MICROSOFT CORP (0000789019) (Issuer)

    2/18/26 6:14:22 PM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    Director Smith Gary B bought $313 worth of shares (20 units at $15.66) and sold $254 worth of shares (20 units at $12.69) (SEC Form 4)

    4 - Planet Labs PBC (0001836833) (Issuer)

    2/3/26 6:35:28 PM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    President/CEO Gilad Oren bought $25,009 worth of shares (28,100 units at $0.89), increasing direct ownership by 8% to 373,720 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:08:08 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $ADTX
    $AEHR
    $AKRO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst reiterated coverage on Wayfair with a new price target

    Analyst reiterated coverage of Wayfair with a rating of Overweight and set a new price target of $105.00 from $114.00 previously

    2/20/26 10:42:01 AM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    Upstart upgraded by Compass Point with a new price target

    Compass Point upgraded Upstart from Sell to Neutral and set a new price target of $30.00

    2/17/26 8:05:30 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Upstart downgraded by Citizens with a new price target

    Citizens downgraded Upstart from Mkt Perform to Mkt Underperform and set a new price target of $20.00

    2/13/26 8:31:11 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    $AAPL
    $ADTX
    $AEHR
    $AKRO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Upstart Announces Inaugural $200M Upstart Auto Forward-Flow Agreement with Wafra

    Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, today announced a forward-flow commitment from funds managed by Wafra, a New York-based global alternative investment manager focused on strategic partnerships, real estate and real assets. Wafra has agreed to purchase up to $200 million of assets originated through the Upstart auto finance platform. "We are pleased to partner with Upstart on its inaugural auto finance forward-flow program," said Paul Steinberger, Managing Director at Wafra. "This partnership exemplifies how we work with leaders in the asset-based finance ecosystem on strategies to deliver credit exposures that offer compel

    2/20/26 8:05:00 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Upstart Announces $333M Sale of Upstart Auto Assets to Affiliates of Bayview Asset Management, LLC

    Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, today announced the previous sale of a $333 million aggregate portfolio of Upstart Auto assets to affiliates of Bayview Asset Management, LLC. "Upstart is a strong strategic fit with Bayview's focus on disciplined capital deployment in the auto lending market," said Carlos Prevolis, Managing Director at Bayview. "We've been impressed by Upstart's growth and leadership in auto lending and look forward to continuing to strengthen our partnership." The auto portfolio sale is the first major transaction between Upstart and Bayview. It demonstrates growing interest in Upstart's scaling auto pl

    2/20/26 8:00:00 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026

    CAMBRIDGE, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, will report fourth quarter and full year 2025 financial results and corporate highlights after the U.S. financial markets close on Thursday, February 26, 2026. About Relay Therapeutics Relay Therapeutics (NASDAQ:RLAY) is a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease. Relay's Dynamo® platform integrates an array of leading-edge co

    2/19/26 5:55:00 PM ET
    $RLAY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAPL
    $ADTX
    $AEHR
    $AKRO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    FDA Approval for ATTRUBY issued to BRIDGEBIO PHARMA INC

    Submission status for BRIDGEBIO PHARMA INC's drug ATTRUBY (ORIG-1) with active ingredient ACORAMIDIS has changed to 'Approval' on 11/22/2024. Application Category: NDA, Application Number: 216540, Application Classification: Type 1 - New Molecular Entity

    11/25/24 8:41:11 AM ET
    $BBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    September 17, 2024 - FDA Roundup: September 17, 2024

    For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

    9/17/24 2:34:22 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $ADTX
    $AEHR
    $AKRO
    SEC Filings

    View All

    SEC Form 144 filed by Upstart Holdings Inc.

    144 - Upstart Holdings, Inc. (0001647639) (Subject)

    2/20/26 4:06:33 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    SEC Form 144 filed by Upstart Holdings Inc.

    144 - Upstart Holdings, Inc. (0001647639) (Subject)

    2/20/26 4:05:19 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    SEC Form 144 filed by Motorsport Games Inc.

    144 - Motorsport Games Inc. (0001821175) (Subject)

    2/20/26 12:10:50 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $ADTX
    $AEHR
    $AKRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Magnuson William sold $447,172 worth of shares (26,413 units at $16.93), decreasing direct ownership by 0.58% to 4,491,098 units (SEC Form 4)

    4 - Braze, Inc. (0001676238) (Issuer)

    2/20/26 4:37:15 PM ET
    $BRZE
    Computer Software: Prepackaged Software
    Technology

    Chief Accounting Officer Malik Pankaj sold $48,978 worth of shares (2,893 units at $16.93), decreasing direct ownership by 5% to 50,679 units (SEC Form 4)

    4 - Braze, Inc. (0001676238) (Issuer)

    2/20/26 4:36:21 PM ET
    $BRZE
    Computer Software: Prepackaged Software
    Technology

    Chief Technology Officer Hyman Jonathan sold $125,130 worth of shares (7,391 units at $16.93), decreasing direct ownership by 0.43% to 1,692,933 units (SEC Form 4)

    4 - Braze, Inc. (0001676238) (Issuer)

    2/20/26 4:35:36 PM ET
    $BRZE
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $ADTX
    $AEHR
    $AKRO
    Leadership Updates

    Live Leadership Updates

    View All

    VNET Appoints New Officer to Finance Leadership Team

    BEIJING, Feb. 13, 2026 /PRNewswire/ -- VNET Group, Inc. (NASDAQ:VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced the appointment of Mr. Peter Zhihua Zhang as Senior Vice President, Operational Finance, effective immediately. Mr. Zhang will be responsible for the Company's financial operations and is authorized to review and approve the Company's financial statements and related filings for SEC and Nasdaq compliance purposes, as applicable. Mr. Zhang will also serve as the Company's "principal accounting officer" in accordance with applicable U.S. federal securities laws, SEC rules, and Nasdaq requirements.

    2/13/26 7:00:00 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    $AAPL
    $ADTX
    $AEHR
    $AKRO
    Financials

    Live finance-specific insights

    View All

    Wayfair Announces Fourth Quarter and Full Year 2025 Results, Reports Further Share Capture and Strong Profitability

    Q4 Net Revenue of $3.3 billion with 21.3 million Active CustomersBOSTON, Feb. 19, 2026 /PRNewswire/ -- Wayfair Inc. ("Wayfair," "we," or "our") (NYSE:W), the destination for all things home, today reported financial results for its fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial HighlightsTotal net revenue of $3.3 billion, increased $216 million, up 6.9% year over year. Total net revenue excluding the impact of our exit from the German market grew 7.8% year over yearU.S. net revenue of $2.9 billion, increased $202 million, up 7.4% year over ye

    2/19/26 7:00:00 AM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    Carvana Announces Record Fourth Quarter and Full Year 2025 Results

    Record Full Year Retail Units Sold of 596,641, up 43% YoY Record Full Year Revenue of $20.3 billion, up 49% YoY Record Full Year Net Income of $1.9 billion1, up more than $1 billion YoY Record Full Year Adjusted EBITDA of $2.2 billion, up more than $850 million YoY Expects Significant Growth in Retail Units Sold and Adjusted EBITDA2 in FY 2026 and Sequential Increase in Retail Units Sold and Adjusted EBITDA2 in Q1 Carvana (NYSE:CVNA), a leading e-commerce platform for buying and selling cars, today announced financial results for the full year and quarter ended December 31, 2025. Carvana's complete fourth quarter and fiscal year 2025 financial results and management commentary are

    2/18/26 4:05:00 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    BridgeBio to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 24, 2026 at 4:30 pm ET

    PALO ALTO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that it will release its fourth quarter and full year 2025 financial results and business updates after the market closes on Tuesday, February 24, 2026. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day. To access the live webcast of BridgeBio's presentation, please visit the "Events & Presentations" page within the Investors section of the BridgeBio website at investor.bridgebio.com/events-and-presentat

    2/17/26 7:30:00 AM ET
    $BBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $ADTX
    $AEHR
    $AKRO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Rocket Pharmaceuticals Inc.

    SC 13D/A - ROCKET PHARMACEUTICALS, INC. (0001281895) (Subject)

    12/16/24 7:51:51 PM ET
    $RCKT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by PolyPid Ltd.

    SC 13G/A - PolyPid Ltd. (0001611842) (Subject)

    12/12/24 7:05:07 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care